MedTrace Logo

Tu Salud (Your Health) Randomized Control Study in Patients With Diabetes Using a Mobile App.

NCT03556605 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-01-31

No results posted yet for this study

Summary

The study seeks to demonstrate the clinical value and user acceptance of the Bluetooth enabled OneTouch Verio® Flex meter (Flex) used in combination with the OneTouch Reveal® Mobile APP to support overall diabetes care, glycemic control and patient reported outcomes in patients with diabetes in an undeserved population.

Conditions

Interventions

OTHER

OneTouch Reveal® Mobile APP system

Improved glycemic control in people with diabetes using the OneTouch Verio® Flex Blood Glucose Monitor and the OneTouch Reveal® Mobile APP system (intervention group) compared to subjects continuing to use their own Blood Glucose Monitor without connection to mobile diabetes apps (control group).

OTHER

Current Blood Glucose Monitor

Subjects continue to use current Blood Glucose Monitor without connection to mobile diabetes apps.

Sponsors & Collaborators

  • LifeScan

    lead INDUSTRY

Principal Investigators

  • Frederico Ceppa · La Comunidad Hispana Health Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2019-09-15
Completion
2019-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556605 on ClinicalTrials.gov